S-Cain peeling

S-Cain peeling

S-Cain peeling

Treatment for: Topical local anesthesia

The US Food and Drug Administration (FDA) has approved a topical local anesthetic peel developed under the name S-Caine Peel (Lidocaine and Tetracaine) 7%/7% Cream.

Lidocaine and Tetracaine Cream 7%/7% is a topical local anesthetic cream that exfoliates the skin when exposed to air. The approved product is applied 20 to 30 minutes before procedures such as dermal filler injections or facial laser ablation and for 60 minutes during procedures such as laser-assisted tattoo removal.

Robert Lippert, President and Chief Executive Office of ZARS Pharma, stated: "We are pleased with the FDA approval. This product offers physicians a new way to relieve patients' pain during common cosmetic and aesthetic procedures. I am also very proud." the ZARS organization as this approval represents the second NDA approval in the last 12 months.”

In clinical trials, the most common adverse reactions were local skin reactions such as erythema, bleaching and edema. Lidocaine and Tetracaine Cream 7%/7% should not be used for longer than recommended and is contraindicated in patients with a known history of hypersensitivity to lidocaine, tetracaine or amide or ester type local anesthetics. The FDA has not yet approved a brand name; A brand name must be approved by the FDA before the product is marketed in the United States.

More information